China

Medical Device Manufacturers Eye Costa Rica as Tariff Uncertainty Shakes up Production Strategies
Medtech Dive
Wed, 02/26/25 - 10:19 pm
Medtech
device manufacturing
tariffs
China
Costa Rica
AstraZeneca builds in China as Cosette buys Mayne
Pharmaphorum
Fri, 02/21/25 - 11:09 am
M&A
Cosette
Mayne Pharma
AstraZeneca
China
FibroGen
AstraZeneca deepens China presence with FibroGen deal
BioPharma Dive
Thu, 02/20/25 - 11:52 am
AstraZeneca
FDA
FibroGen
China
roxadustat
Trump’s tariffs will trickle down the clinical trial chain
Clinical Trials Arena
Tue, 02/11/25 - 09:34 pm
tariffs
Donald Trump
clinical trials
China
Tariffs raise concern among generic drugmakers, as advocacy groups seek exemptions
BioPharma Dive
Tue, 02/11/25 - 11:29 am
tariffs
China
Canada
Mexico
Donald Trump
generics
Pressure relieved on AZ as details of Chinese probe emerge
Pharmaphorum
Thu, 02/6/25 - 11:32 am
AstraZeneca
China
AstraZeneca shareholders say they need clarity on China investigations
MSN/Reuters
Wed, 02/5/25 - 10:46 pm
AstraZeneca
China
China puts PVH Corp, Illumina on its unreliable entity list
Yahoo/Reuters
Tue, 02/4/25 - 06:36 pm
Medtech
China
Illumina
Merck’s 2025 revenue outlook falls short as it pauses Gardasil vaccine shipments to China
CNBC
Tue, 02/4/25 - 09:36 am
Merck
earnings
Gardasil
China
Stopwatch starts on reviews of GSK's long-acting asthma drug
Pharmaphorum
Tue, 01/28/25 - 10:19 am
GSK
asthma
depemokimab
Europe
China
Japan
The biopharma industry outlook on 2025: Uncertainty and change
BioPharma Dive
Sun, 01/26/25 - 04:16 pm
biotech
JPMHC 2025
China
regulatory
Donald Trump
GSK, Merck and Pfizer in Ab&B’s sights as Chinese vaccine biotech files for IPO
Fierce Biotech
Thu, 01/23/25 - 11:40 am
Ab&B Bio-Tech
GSK
Merck
Pfizer
China
vaccines
IPOs
BMS, Takeda's Chinese partners file for IPOs, sending Ascentage, Biokin and Bao bundling toward listings
Fierce Biotech
Wed, 01/22/25 - 07:28 pm
China
Takeda
Bristol Myers Squibb
IPOs
Ascentage Pharma
Sichuan Biokin Pharmaceutical
Shanghai Bao
AstraZeneca overhauls management of its scandal-hit China division
Financial Times
Fri, 01/17/25 - 11:22 am
AstraZeneca
China
The Rise of China Innovation in the Time of Trump
BioSpace
Thu, 01/16/25 - 11:22 am
China
innovation
Donald Trump
trade
5 questions facing emerging biotech in 2025
BioPharma Dive
Tue, 01/14/25 - 11:22 am
biotech
funding
China
IPOs
cell therapy
gene therapy
M&A
The ability to pivot will be ‘key’ as pharma’s tariff threat looms
Pharma Voice
Mon, 01/13/25 - 11:16 am
Donald Trump
tariffs
China
Mexico
drug pricing
CARsgen gets a win for CAR-T in solid tumors
Pharmaphorum
Fri, 01/3/25 - 09:55 am
CARsgen
solid tumors
satri-cel
CAR-T
China
Roche Kicks Off 2025 Committing a Potential $1B for Another ADC From China
BioSpace
Thu, 01/2/25 - 11:37 am
Roche
China
antibody-drug conjugates
small cell lung cancer
Trump tariffs and drug prices: 3 notes
Beckers Hospital Review
Thu, 01/2/25 - 11:16 am
Donald Trump
drug pricing
tarriffs
Mexico
Canada
China

Pages